---
title: "Bon Secours Mercy Health to buy Surgery Partners in $5.7B deal for ASC chain"
id: "news-news-stat-5ad05f575cda2894febd9800"
canonical_url: "https://medichelpline.com/news/news-news-stat-5ad05f575cda2894febd9800"
content_type: "medical_news_article"
category: "Business"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/10/26/bon-secours-mercy-health-surgery-partners-deal-ambulatory-surgery-centers-bain-capital/?utm_campaign=rss"
published_at: "2026-10-26T21:54:24.000Z"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Bon Secours Mercy Health to buy Surgery Partners in $5.7B deal for ASC chain
## Metadata & Source Attribution
- **Canonical URL:** https://medichelpline.com/news/news-news-stat-5ad05f575cda2894febd9800
- **Category:** [Business](https://medichelpline.com/news/business.md)
- **Reporting Source:** STAT News
- **Original Source URL:** [Read Original Article](https://www.statnews.com/2026/10/26/bon-secours-mercy-health-surgery-partners-deal-ambulatory-surgery-centers-bain-capital/?utm_campaign=rss)
- **Published At:** 2026-10-26T21:54:24.000Z
## Executive Summary & Key Highlights
- Bon Secours Mercy Health, a nonprofit Catholic health system, announced plans to acquire **Surgery Partners** in a deal valued at **$5.7 billion**. The chain operates more than 200 ambulatory surgery centers, short-stay hospitals, and multispecialty physician practices across 30 states. - The transaction is expected to close in the **first quarter of 2027** and would make Bon Secours Mercy Health one of the nation’s largest operators of ambulatory surgery centers (**ASCs**). - The acquisition would strengthen the system’s relationship with private equity firm **Bain Capital**, which is involved in Surgery Partners’ ownership structure, according to the announcement. - Industry trend: hospital systems have been rapidly acquiring ASCs as procedures shift to outpatient settings and payers encourage lower-cost sites of care. Earlier in 2026, nonprofit **Ascension** paid **$3.9 billion** for Amsurg to expand its ASC network. - Observers say the move could increase Bon Secours Mercy Health’s profitability and bargaining power with health insurers. The source did not provide further financial projections or details on regulatory review or integration plans.
## In-Depth Reporting & Editorial Analysis
## Bon Secours Mercy Health announces $5.7 billion acquisition of Surgery Partners Bon Secours Mercy Health, a nonprofit Catholic health system, said Monday it intends to acquire **Surgery Partners**, a publicly traded chain that operates more than 200 ambulatory surgery centers, short-stay hospitals, and multispecialty physician practices in 30 states. The transaction is valued at **$5.7 billion** and is expected to close in the **first quarter of 2027**, according to the announcement. The deal would position Bon Secours Mercy Health among the largest operators of outpatient surgery facilities in the United States and would deepen the health system’s existing relationship with private equity firm **Bain Capital**, which is tied to Surgery Partners’ ownership. ## Why this move matters for hospitals, insurers, and patients Hospital operators of all types have been buying ambulatory surgery centers (ASCs) at a brisk pace in recent years. Industry observers and the reporting in the source note several drivers behind that trend: - Procedures are increasingly moving into outpatient settings under recent and ongoing **Medicare** payment changes and other reimbursement shifts. - Commercial insurers are steering patients toward lower-cost facilities, making ASCs an attractive alternative to inpatient hospitals for many surgical procedures. By acquiring Surgery Partners, Bon Secours Mercy Health could boost its profitability and increase its negotiating leverage with health insurers, the reporting said. The source did not provide specific projected financial impacts, expected cost savings, or details about how the system plans to integrate Surgery Partners’ operations. ## The scope of Surgery Partners’ footprint Surgery Partners operates a mix of ambulatory surgery centers, short-stay hospitals, and physician practice groups across 30 states. The company’s network exceeds 200 sites, a scale that would substantially expand Bon Secours Mercy Health’s outpatient surgery capacity if the deal closes as planned. The announcement linked the transaction to Bain Capital, indicating that the acquisition will deepen ties between the nonprofit system and the private equity firm. The source did not disclose the ownership breakdown, transaction structure, or financing details beyond the headline purchase price. ## Industry context: recent large ASC acquisitions The purchase of Surgery Partners is part of a broader consolidation trend among hospital systems and investors. The source points to a comparable deal earlier in 2026: nonprofit Ascension paid **$3.9 billion** for Amsurg, which expanded that system’s network of ambulatory surgery centers to roughly 300 sites. These transactions reflect a strategic bet by hospital systems that expanding outpatient capabilities will capture volume and revenue as more procedures migrate away from inpatient settings. The source did not include independent analysis of market concentration, regional impacts, or expected effects on patient access or prices. ## Potential implications and unanswered questions According to the reporting, the acquisition could strengthen Bon Secours Mercy Health’s market position and financial performance. At the same time, several practical and regulatory questions remain unanswered in the source material: - The source did not report whether the deal will face antitrust or regulatory review, or what conditions, if any, might be imposed. - Details on how Bon Secours Mercy Health intends to manage Surgery Partners’ existing contracts, insurance relationships, and clinicians were not provided. - The announcement did not include projections for job impacts, changes to patient billing or care pathways, or integration timelines beyond the expected closing window in Q1 2027. Those are typical issues in major health-system acquisitions, but the source did not supply additional specifics. ## What comes next Bon Secours Mercy Health said it plans to complete the transaction in the first quarter of 2027. Between now and closing, standard steps for deals of this size would typically include due diligence, financing arrangements, and any required regulatory reviews. The source did not describe the timeline or milestones that must be met before the acquisition is finalized. Observers will likely watch for how the merged organization positions its outpatient network, how payers respond, and whether the deal spurs further consolidation among hospital systems seeking scale in ambulatory services. The source did not report comments from payers, regulators, or patient advocates. ## Reporting details This coverage is based on the announcement reported by the source on Oct. 26, 2026. The author of the original piece is Tara Bannow, Hospitals and Insurance Reporter. The facts in this report are drawn from that announcement and the source’s contextual reporting. Where the source did not provide further information — for example, on deal financing, regulatory reviews, or integration plans — those specifics are noted as not reported. ## Bottom line If completed, the $5.7 billion acquisition of **Surgery Partners** would significantly expand Bon Secours Mercy Health’s ambulatory surgery footprint and align the nonprofit more closely with private equity interests via Bain Capital. The transaction arrives amid a broader industry shift toward outpatient care and follows other large ASC purchases, including Ascension’s $3.9 billion buy of Amsurg earlier in 2026. The full implications for competition, prices, and patient care will depend on details the source did not report and on developments during the remaining deal process.
## Navigation
- [← Back to Business News](https://medichelpline.com/news/business.md)
- [← All Medical News Categories](https://medichelpline.com/news.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.